n(alpha)-(2-naphthylsulfonylglycyl)-4-amidinophenylalanine piperidide has been researched along with Neurodegenerative Diseases in 1 studies
N(alpha)-(2-naphthylsulfonylglycyl)-4-amidinophenylalanine piperidide: thrombin inhibitor; RN given refers to parent cpd without isomeric designation
Neurodegenerative Diseases: Hereditary and sporadic conditions which are characterized by progressive nervous system dysfunction. These disorders are often associated with atrophy of the affected central or peripheral nervous system structures.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Carreño-Müller, E | 1 |
| Herrera, AJ | 1 |
| de Pablos, RM | 1 |
| Tomás-Camardiel, M | 1 |
| Venero, JL | 1 |
| Cano, J | 1 |
| Machado, A | 1 |
1 other study available for n(alpha)-(2-naphthylsulfonylglycyl)-4-amidinophenylalanine piperidide and Neurodegenerative Diseases
| Article | Year |
|---|---|
Thrombin induces in vivo degeneration of nigral dopaminergic neurones along with the activation of microglia.
Topics: Animals; Antithrombins; Corpus Striatum; Dipeptides; Dopamine; Dose-Response Relationship, Drug; Enz | 2003 |